Valeant acquires iNova
Valeant Pharmaceuticals International, Inc. announced that effective December 21, 2011, the company completed its previously announced acquisition of iNova, from Archer Capital, Ironbridge and other minority management shareholders.
BofA Merrill Lynch and Baker & McKenzie acted as Valeant’s advisors in connection with this transaction.
Tags: Inova Posted in